10-Q 1 ldr-20150331x10q.htm 10-Q ldr-20150331 10Q Q2

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2015

 

Commission File Number 1-9788

 

 

 

 

 

 

LANDAUER, INC.

(Exact Name of registrant as specified in its charter)

 

 

 

 

 

 

Delaware

06-1218089

 

 

(State or other jurisdiction of

Incorporation or organization)

(I.R.S. Employer

Identification Number)

 

 

 

 

 

 

2 Science Road, Glenwood, IL  60425

(Address of principal executive offices and zip code)

 

 

 

 

 

 

Registrant’s telephone number, including area code:  (708) 755-7000

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes [ X ]    No [    ]

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes [ X ]    No [    ]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

 

 

 

 

 

 

 

 

Large accelerated filer

[    ]

 

Accelerated filer

[ X ]

 

 

Non-accelerated filer

[    ]

 

Smaller reporting company

[    ]

 

 

(Do not check if a smaller reporting company)

 

 

 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes [     ]    No [  X  ]

 

As of May 4, 2015, 9,578,618 shares of common stock, par value $0.10 per share, of the registrant were outstanding.

 

1

 


 

 

TABLE OF CONTENTS

 

 

 

 

 

 

 

 

 

 

 

 

PART I    FINANCIAL INFORMATION 

 

 

 

 

 

 

 

Item 1.

Financial Statements

 

 

 

 

 

 

 

 

 

Consolidated Balance Sheets (Unaudited)

3

 

 

 

 

 

 

 

 

Consolidated Statements of Operations (Unaudited)

4

 

 

 

 

 

 

 

 

Consolidated Statements of Comprehensive Income (Unaudited)

5

 

 

 

 

 

 

 

 

Consolidated Statement of Stockholders’ Equity (Unaudited)

6

 

 

 

 

 

 

 

 

Consolidated Statements of Cash Flows (Unaudited)

7

 

 

 

 

 

 

 

 

Notes to Consolidated Financial Statements (Unaudited)

8

 

 

 

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

20

 

 

 

 

 

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

26

 

 

 

 

 

 

Item 4.

Controls and Procedures

26

 

 

 

 

 

 

 

 

 

 

 

PART II    OTHER INFORMATION

 

 

 

 

 

 

 

Item 1.

Legal Proceedings

29

 

 

 

 

 

 

Item 1A.

Risk Factors

29

 

 

 

 

 

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

30

 

 

 

 

 

 

Item 3.

Defaults Upon Senior Securities

30

 

 

 

 

 

 

Item 4.

Mine Safety Disclosures

30

 

 

 

 

 

Item 5.

Other Information

30

 

 

 

 

 

Item 6.

Exhibits

31

 

 

 

 

 

 

 

 

 

 

 

SIGNATURE 

32

 

 

 

 

 

 

 

 

2

 


 

PART I  FINANCIAL INFORMATION

  Item 1.Financial Statements

LANDAUER, INC. AND SUBSIDIARIES

Consolidated Balance Sheets (Unaudited)

 

 

 

 

 

 

 

 

 

 

(Dollars in Thousands)

 

March 31,
2015

 

September 30,
2014

ASSETS

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

8,424 

 

$

6,761 

Receivables, net of allowances of $1,703 at March 31, 2015 and $1,872 at September 30, 2014

 

 

30,756 

 

 

34,707 

Inventories

 

 

6,689 

 

 

6,687 

Deferred income tax asset - current

 

 

2,348 

 

 

2,369 

Prepaid income taxes

 

 

2,131 

 

 

1,836 

Prepaid expenses and other current assets

 

 

2,562 

 

 

1,973 

Current assets

 

 

52,910 

 

 

54,333 

Property, plant and equipment, at cost

 

 

107,404 

 

 

104,010 

Accumulated depreciation and amortization

 

 

(60,431)

 

 

(57,253)

Net property, plant and equipment

 

 

46,973 

 

 

46,757 

Equity in joint ventures

 

 

23,137 

 

 

23,835 

Goodwill

 

 

40,432 

 

 

43,218 

Intangible assets, net of accumulated amortization of $37,624 at March 31, 2015 and $37,579 at September 30, 2014

 

 

13,369 

 

 

14,077 

Dosimetry devices, net of accumulated depreciation of $4,734 at March 31, 2015 and $4,353 at September 30, 2014

 

 

3,595 

 

 

3,958 

Deferred income tax assets

 

 

19,619 

 

 

18,374 

Other assets

 

 

8,922 

 

 

12,034 

ASSETS

 

$

208,957 

 

$

216,586 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

 

$

6,880 

 

$

6,248 

Dividends payable

 

 

2,700 

 

 

5,329 

Deferred contract revenue

 

 

15,178 

 

 

14,750 

Accrued compensation and related costs

 

 

7,098 

 

 

7,132 

Accrued severance

 

 

557 

 

 

2,731 

Other accrued expenses

 

 

7,182 

 

 

8,538 

Current liabilities

 

 

39,595 

 

 

44,728 

Non-current liabilities:

 

 

 

 

 

 

Long-term debt

 

 

134,585 

 

 

133,585 

Pension and postretirement obligations

 

 

19,101 

 

 

19,475 

Deferred income taxes

 

 

431 

 

 

509 

Uncertain income tax liabilities

 

 

3,391 

 

 

3,284 

Other non-current liabilities

 

 

1,260 

 

 

1,271 

Non-current liabilities

 

 

158,768 

 

 

158,124 

Stockholders' equity:

 

 

 

 

 

 

Preferred stock, $.10 par value per share, authorized 1,000,000 shares; none issued

 

 

 -

 

 

 -

Common stock, $.10 par value per share, authorized 20,000,000 shares; 9,657,625 and 9,577,874 shares issued and outstanding at March 31, 2015 and September 30, 2014, respectively

 

 

966 

 

 

958 

Additional paid in capital

 

 

41,064 

 

 

40,317 

Accumulated other comprehensive loss

 

 

(13,753)

 

 

(10,148)

Accumulated deficit

 

 

(18,916)

 

 

(18,873)

Landauer, Inc. stockholders' equity

 

 

9,361 

 

 

12,254 

Noncontrolling interest

 

 

1,233 

 

 

1,480 

Stockholders' equity

 

 

10,594 

 

 

13,734 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

$

208,957 

 

$

216,586 

The accompanying notes are an integral part of these consolidated financial statements.

3

 


 

LANDAUER, INC. AND SUBSIDIARIES

Consolidated Statements of Operations (Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended
March 31,

 

 

Six Months Ended
March 31,

(Dollars in Thousands, Except per Share)

 

2015

 

2014
(As Restated)

 

2015

 

2014
(As Restated)

Service revenues

 

$

32,242 

 

$

32,870 

 

$

64,299 

 

$

64,615 

Product revenues

 

 

5,897 

 

 

6,184 

 

 

11,387 

 

 

12,586 

Net revenues

 

 

38,139 

 

 

39,054 

 

 

75,686 

 

 

77,201 

Costs and expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Service costs

 

 

16,158 

 

 

15,155 

 

 

31,792 

 

 

30,165 

Product costs

 

 

2,453 

 

 

3,177 

 

 

4,570 

 

 

6,552 

Total cost of sales

 

 

18,611 

 

 

18,332 

 

 

36,362 

 

 

36,717 

Gross profit

 

 

19,528 

 

 

20,722 

 

 

39,324 

 

 

40,484 

Selling, general and administrative

 

 

13,898 

 

 

13,750 

 

 

27,553 

 

 

27,976 

Acquisition, reorganization and nonrecurring costs

 

 

 -

 

 

109 

 

 

 -

 

 

220 

Operating income

 

 

5,630 

 

 

6,863 

 

 

11,771 

 

 

12,288 

Equity in income of joint ventures

 

 

680 

 

 

535 

 

 

1,376 

 

 

1,816 

Interest expense, net

 

 

(964)

 

 

(1,014)

 

 

(1,917)

 

 

(1,951)

Other (expense) income, net

 

 

(485)

 

 

 

 

(234)

 

 

164 

Income before taxes

 

 

4,861 

 

 

6,389 

 

 

10,996 

 

 

12,317 

Income tax expense

 

 

1,180 

 

 

1,913 

 

 

2,790 

 

 

3,812 

Net income

 

 

3,681 

 

 

4,476 

 

 

8,206 

 

 

8,505 

Less:  Net income (loss) attributed to noncontrolling interest

 

 

134 

 

 

(38)

 

 

282 

 

 

170 

Net income attributed to Landauer, Inc.

 

$

3,547 

 

$

4,514 

 

$

7,924 

 

$

8,335 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income per share attributable to Landauer, Inc. shareholders:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.37 

 

$

0.47 

 

$

0.83 

 

$

0.87 

Weighted average basic shares outstanding

 

 

9,493 

 

 

9,460 

 

 

9,464 

 

 

9,441 

Diluted

 

$

0.37 

 

$

0.47 

 

$

0.83 

 

$

0.87 

Weighted average diluted shares outstanding

 

 

9,520 

 

 

9,501 

 

 

9,492 

 

 

9,485 

 

The accompanying notes are an integral part of these consolidated financial statements.

4

 


 

LANDAUER, INC. AND SUBSIDIARIES

Consolidated Statements of Comprehensive Income (Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended
March 31, 2015

 

Six Months Ended
March 31, 2015

(Dollars in Thousands)

 

Landauer, Inc.

 

Noncontrolling
Interest

 

Total

 

Landauer, Inc.

 

Noncontrolling
Interest

 

Total

Net income

 

$

3,547 

 

$

134 

 

$

3,681 

 

$

7,924 

 

$

282 

 

$

8,206 

Other comprehensive income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Defined benefit pension and postretirement plans activity, net of taxes of $53

 

 

19 

 

 

 -

 

 

19 

 

 

91 

 

 

 -

 

 

91 

Unrealized gains (losses) on available-for-sale securities, net of taxes of $0

 

 

37 

 

 

 -

 

 

37 

 

 

 

 

 -

 

 

Foreign currency translation adjustment, net of taxes of $1,103, and $2,057, respectively

 

 

(1,927)

 

 

(99)

 

 

(2,026)

 

 

(3,698)

 

 

(198)

 

 

(3,896)

Comprehensive income

 

$

1,676 

 

$

35 

 

$

1,711 

 

$

4,319 

 

$

84 

 

$

4,403 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended
March 31, 2014

 

Six Months Ended
March 31, 2014

 

 

(As Restated)

 

(As Restated)

(Dollars in Thousands)

 

Landauer, Inc.

 

Noncontrolling
Interest

 

Total

 

Landauer, Inc.

 

Noncontrolling
Interest

 

Total

Net income

 

$

4,514 

 

$

(38)

 

$

4,476 

 

$

8,335 

 

$

170 

 

$

8,505 

Other comprehensive income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Defined benefit pension and postretirement plans activity, net of taxes of $0

 

 

46 

 

 

 

 

 

46 

 

 

91 

 

 

 

 

 

91 

Unrealized gains (losses) on available-for-sale securities, net of taxes of $0

 

 

25 

 

 

 

 

 

25 

 

 

(54)

 

 

 

 

 

(54)

Foreign currency translation adjustment, net of taxes of $0

 

 

409 

 

 

19 

 

 

428 

 

 

153 

 

 

(49)

 

 

104 

Comprehensive income

 

$

4,994 

 

$

(19)

 

$

4,975 

 

$

8,525 

 

$

121 

 

$

8,646 

 

The accompanying notes are an integral part of these consolidated financial statements.

5

 


 

LANDAUER, INC. AND SUBSIDIARIES

Consolidated Statement of Stockholders’ Equity (Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Landauer, Inc. Stockholders' Equity

 

 

 

 

 

 

(Dollars in Thousands)

Common
Stock
Shares

 

Common
Stock

 

Addi-
tional
Paid in
Capital

 

Accumulated Other Compre-hensive (Loss) Income

 

(Accumulated Deficit) Retained
Earnings

 

Non-
Controlling
Interest

 

Total
Stock-
holders'
Equity

September 30,
2014

 

9,577,874 

 

$

958 

 

$

40,317 

 

$

(10,148)

 

$

(18,873)

 

$

1,480 

 

$

13,734 

Stock-based compensation arrangements

 

79,751 

 

 

 

 

747 

 

 

 -

 

 

 -

 

 

 -

 

 

755 

Dividends

 

 -

 

 

 -

 

 

 -

 

 

 -

 

 

(7,967)

 

 

(331)

 

 

(8,298)

Net income

 

 -

 

 

 -

 

 

 -

 

 

 -

 

 

7,924 

 

 

282 

 

 

8,206 

Foreign currency translation adjustment, net of tax

 

 -

 

 

 -

 

 

 -

 

 

(3,698)

 

 

 -

 

 

(198)

 

 

(3,896)

Unrealized gains (losses) on available-for-sale securities, net of tax

 

 -

 

 

 -

 

 

 -

 

 

 

 

 -

 

 

 -

 

 

Defined benefit pension and postretirement plans activity, net of tax

 

 -

 

 

 -

 

 

 -

 

 

91 

 

 

 -

 

 

 -

 

 

91 

March 31,
2015

 

9,657,625 

 

$

966 

 

$

41,064 

 

$

(13,753)

 

$

(18,916)

 

$

1,233 

 

$

10,594 

 

The accompanying notes are an integral part of these consolidated financial statements.

6

 


 

LANDAUER, INC. AND SUBSIDIARIES

Consolidated Statements of Cash Flows (Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended
March 31,

(Dollars in Thousands)

 

2015

 

2014
(As Restated)

Cash flows from operating activities:

 

 

 

 

 

 

Net income

 

$

8,206 

 

$

8,505 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

6,092 

 

 

7,487 

Equity in income of joint ventures

 

 

(1,376)

 

 

(1,816)

Dividends from joint ventures

 

 

1,144 

 

 

1,340 

Stock-based compensation and related net tax benefits

 

 

873 

 

 

453 

Current and long-term deferred taxes, net

 

 

(1,792)

 

 

847 

Loss on sale, disposal and abandonment of fixed assets

 

 

124 

 

 

 -

Gain on investments

 

 

(189)

 

 

(338)

Changes in operating assets and liabilities:

 

 

 

 

 

 

Decrease in accounts receivable, net

 

 

2,923 

 

 

3,205 

(Increase) decrease in prepaid taxes

 

 

(385)

 

 

1,027 

Decrease in other operating assets, net

 

 

347 

 

 

761 

Decrease in accounts payable and other accrued liabilities

 

 

(1,002)

 

 

(2,021)

(Decrease) increase in other operating liabilities, net

 

 

(108)

 

 

430 

Net cash provided by operating activities

 

 

14,857 

 

 

19,880 

Cash flows used by investing activities:

 

 

 

 

 

 

Acquisition of property, plant and equipment

 

 

(3,063)

 

 

(2,415)

Acquisition of joint ventures and businesses, net of cash acquired

 

 

 -

 

 

(1,800)

Other investing activities, net

 

 

147 

 

 

(114)

Net cash used by investing activities

 

 

(2,916)

 

 

(4,329)

Cash flows (used) provided by financing activities:

 

 

 

 

 

 

Net borrowings on revolving credit facility

 

 

 -

 

 

(43)

Long-term borrowings - loan

 

 

16,300 

 

 

20,000 

Long-term borrowings - repayment

 

 

(15,300)

 

 

(24,500)

Dividends paid to stockholders

 

 

(10,599)

 

 

(10,520)

Other financing activities, net

 

 

(321)

 

 

(347)

Net cash used by financing activities

 

 

(9,920)

 

 

(15,410)

Effects of foreign currency translation

 

 

(358)

 

 

109 

Net increase in cash and cash equivalents

 

 

1,663 

 

 

250 

Opening balance - cash and cash equivalents

 

 

6,761 

 

 

8,672 

Ending balance - cash and cash equivalents

 

$

8,424 

 

$

8,922 

 

 

 

 

 

 

 

Accrued capital spending included in accounts payable and other accrued liabilities

 

$

2,272 

 

$

258 

 

The accompanying notes are an integral part of these consolidated financial statements.

7

 


 

LANDAUER, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements (Unaudited)

March  31, 2015

(Dollars in thousands)

 

(1)Basis of Presentation and Consolidation

 

As used herein, the “Company” or “Landauer” refers to Landauer, Inc. and its subsidiaries.

 

The consolidated financial statements include the accounts of the Company, its subsidiaries and variable interest entities in which the Company has a controlling financial interest.  All inter-company balances and transactions are eliminated in consolidation.  Entities in which the Company does not have a controlling financial interest, but is considered to have significant influence, are accounted for on the equity method.

 

The accompanying unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2014 and other financial information filed with the Securities and Exchange Commission (the “SEC”).  The September 30, 2014 balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America (“U.S. GAAP”).

 

The accounting policies followed by the Company are set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2014.  There have been no changes to the accounting policies for the six month period ended March  31, 2015.

 

The results of operations for the three and six month periods ended March  31, 2015  are not necessarily indicative of the results to be expected for the full fiscal year.

 

Restatement and Revision of Prior Period Financial Statements

 

In connection with the preparation of the consolidated financial statements for the fiscal year ended September 30, 2014, the Company identified errors in its previously issued financial statements for the interim periods ended March 31, 2014.  In accordance with accounting guidance presented in ASC 250-10 and SEC Staff Accounting Bulletin No. 99, Materiality, (“SAB 99”) management assessed the materiality of these errors and concluded that they were material to the Company’s financial statements for the three and six months ended March 31, 2014.  The Company restated its financial statements for the three and six month periods ended March 31, 2014 to correct for these errors.  Following is a description of the corrections:

 

Income taxes – The Company did not properly allocate income between taxing jurisdictions for certain items.  This resulted in the misstatement of income tax expense (benefit), prepaid taxes, current and deferred tax assets and liabilities, other accrued expenses and accumulated other comprehensive income.

 

Revenue and accounts receivable – The Company identified the following errors related to revenue recognition and its accounting for receivables:

 

·

The Company did not properly defer revenue for the portion of the badge wear period remaining at the end of each month.  This resulted in the misstatement of revenue and the deferred revenue liability.

·

The Company did not recognize revenue for certain customers in accordance with contractually established terms and conditions.  This resulted in the misstatement of revenue, cost of sales, inventory and the deferred revenue liability.

8

 


 

·

Revenue was recognized for certain product sales prior to the transfer of the risk of loss to customers.  This resulted in the misstatement of revenue, cost of sales, inventory and the deferred revenue liability.

·

Credit memos were recorded to customers’ accounts prior to recognition of the related revenue.  This resulted in the misstatement of revenue and receivables, net of allowances.

·

The Company did not properly record an allowance for credit memos to be issued to customers in the same periods as the related revenue.  This resulted in the misstatement of revenue and receivables, net of allowances.

·

The Company utilized a methodology at one of its foreign subsidiaries to record an allowance for doubtful accounts that did not properly estimate future bad debts based on the subsidiary’s historical experience.  As a result, the Company did not record an allowance for certain significantly aged receivables and bad debt expense was not recorded in the proper periods.  This resulted in the misstatement of selling, general and administrative expenses and receivables, net of allowances.

 

Dosimetry devices – The Company did not properly account for certain dosimetry devices, based on the expected useful life of the devices as determined by the wear period of the related badges.  This resulted in a misstatement of cost of sales and dosimetry devices, net of accumulated depreciation.

 

Long-term investments - The Company recorded fixed income mutual fund investments held by one of its foreign subsidiaries as cash, instead of properly classifying them as available-for-sale securities.  As a result, both realized and unrealized gains were incorrectly recorded as interest income.  This resulted in the misstatement of interest expense, net, other income (expense), net, net income attributed to noncontrolling interest, comprehensive income, cash, other assets, accumulated other comprehensive income, and noncontrolling interest.

 

Sales taxes – The Company did not collect and remit sales taxes to the proper taxing jurisdictions.  This resulted in the misstatement of selling, general and administrative expenses and other accrued expenses.

 

Intangible assets – The Company’s intangible assets include purchased customer lists, licenses, patents, trademarks and tradenames. These assets are recorded at fair value and assigned estimated useful lives at the time of acquisition. The Company did not properly amortize certain customer lists and trademarks based on their assigned useful lives and, therefore, did not record amortization expense in the proper periods.  This resulted in a misstatement of selling, general and administrative expenses and intangible assets, net of accumulated amortization.

 

Equity in joint ventures – The Company identified the following errors related to accounting for its joint ventures:

 

·

During fiscal 2012 and 2013, the Company did not properly record its share of equity income from certain joint ventures in the proper periods.

·

The Company did not properly eliminate intra-entity profit on sales to one of its joint ventures accounted for on the equity method.  This resulted in the misstatement of equity in income of joint ventures and equity in joint ventures (investment account).

·

Revenue was recorded at one of the Company’s joint ventures on equipment sales prior to transfer of the risk of loss to the customer.  As a result, the Company did not record its share of equity income from the joint venture in the proper periods.

 

9

 


 

The following table summarizes the impact of the restatement on net income (loss) and diluted net income (loss) per share attributed to Landauer, Inc. for the three and six months ended March 31, 2014:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Dollars in Thousands, Except per Share Amounts)

 

Three Months Ended
March 31, 2014
(Unaudited)

 

Six Months Ended
March 31, 2014
(Unaudited)

 

 

Net Income (Loss)

 

Diluted Net Income (Loss) Per Share

 

Net Income (Loss)

 

Diluted Net Income (Loss) Per Share

As previously reported

 

$

4,997 

 

$

0.52 

 

$

8,048 

 

$

0.84 

Revenue and accounts receivable

 

 

(500)

 

 

 

 

 

(248)

 

 

 

Dosimetry devices

 

 

13 

 

 

 

 

 

25 

 

 

 

Long-term investments

 

 

(25)

 

 

 

 

 

54 

 

 

 

Sales taxes

 

 

(16)

 

 

 

 

 

(32)

 

 

 

Intangible assets

 

 

 -

 

 

 

 

 

150 

 

 

 

Equity in joint ventures

 

 

 -

 

 

 

 

 

708 

 

 

 

Total adjustments

 

 

(528)

 

 

(0.05)

 

 

657 

 

 

0.07 

Income tax expense (benefit)

 

 

(41)

 

 

 -

 

 

362 

 

 

0.04 

Less amounts attributed to noncontrolling interest

 

 

(4)

 

 

 -

 

 

 

 

 -

Net impact of adjustments

 

 

(483)

 

 

(0.05)

 

 

287 

 

 

0.03 

As restated

 

$

4,514 

 

$

0.47 

 

$

8,335 

 

$

0.87 

 

The effect of the restatement on the previously issued Consolidated Statement of Operations for the three and six months ended March 31, 2014 is as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended
March 31, 2014
(Unaudited)

 

Six Months Ended
March 31, 2014
(Unaudited)

(Dollars in Thousands, Except per Share)

 

Previously Reported

 

As Restated

 

Previously Reported

 

As Restated

Service revenues

 

$

32,983 

 

$

32,870 

 

$

64,877 

 

$

64,615 

Product revenues

 

 

6,571 

 

 

6,184 

 

 

12,382 

 

 

12,586 

Net revenues

 

 

39,554 

 

 

39,054 

 

 

77,259 

 

 

77,201 

Costs and expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Service costs

 

 

15,195 

 

 

15,155 

 

 

30,244 

 

 

30,165 

Product costs

 

 

3,150 

 

 

3,177 

 

 

6,308 

 

 

6,552 

Total cost of sales

 

 

18,345 

 

 

18,332 

 

 

36,552 

 

 

36,717 

Gross profit

 

 

21,209 

 

 

20,722 

 

 

40,707 

 

 

40,484 

Selling, general, and administrative

 

 

13,735 

 

 

13,750 

 

 

28,097 

 

 

27,976 

Acquisition, reorganization and nonrecurring costs

 

 

109 

 

 

109 

 

 

220 

 

 

220 

Operating income

 

 

7,365 

 

 

6,863 

 

 

12,390 

 

 

12,288 

Equity in income of joint ventures

 

 

535 

 

 

535 

 

 

1,108 

 

 

1,816 

Interest expense, net

 

 

(975)

 

 

(1,014)

 

 

(1,867)

 

 

(1,951)

Other income (expense), net

 

 

(8)

 

 

 

 

29 

 

 

164 

Income before taxes

 

 

6,917 

 

 

6,389 

 

 

11,660 

 

 

12,317 

Income tax (benefit) expense

 

 

1,954 

 

 

1,913 

 

 

3,450 

 

 

3,812 

Net income

 

 

4,963 

 

 

4,476 

 

 

8,210 

 

 

8,505 

Less:  Net income attributed to noncontrolling interest

 

 

(34)

 

 

(38)

 

 

162 

 

 

170 

Net income attributed to Landauer, Inc.

 

 

4,997 

 

 

4,514 

 

 

8,048 

 

 

8,335 

Net income per share attributed to Landauer, Inc. shareholders:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

0.52 

 

 

0.47 

 

 

0.84 

 

 

0.87 

Weighted average basic shares outstanding

 

 

9,460 

 

 

9,460 

 

 

9,441 

 

 

9,441 

Diluted

 

 

0.52 

 

 

0.47 

 

 

0.84 

 

 

0.87 

Weighted average diluted shares outstanding

 

 

9,501 

 

 

9,501 

 

 

9,485 

 

 

9,485 

 

10

 


 

The effect of the restatement on the previously issued Consolidated Statement of Cash Flows for the six months ended March 31, 2014 is as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended
March 31, 2014
(Unaudited) (a)

(Dollars in Thousands)

 

Previously Reported

 

As Restated

Cash flows provided from operating activities:

 

 

 

 

 

 

Net income

 

 

8,210 

 

 

8,505 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

7,662 

 

 

7,487 

Gain on investments

 

 

(203)

 

 

(338)

Equity in income of joint ventures

 

 

(1,108)

 

 

(1,816)

Dividends from joint ventures

 

 

1,340 

 

 

1,340 

Stock-based compensation and related net tax benefits

 

 

453 

 

 

453 

Current and long-term deferred taxes, net

 

 

791 

 

 

847 

Changes in operating assets and liabilities:

 

 

 

 

 

 

Decrease in accounts receivable, net

 

 

3,119 

 

 

3,205 

Decrease in prepaid taxes

 

 

721 

 

 

1,027 

Decrease in other operating assets, net

 

 

571 

 

 

761 

Decrease in accounts payable and other accrued liabilities

 

 

(2,025)

 

 

(2,021)

Increase in other operating liabilities, net

 

 

430 

 

 

430 

Net cash provided by operating activities

 

 

19,961 

 

 

19,880 

Cash flows used by investing activities:

 

 

 

 

 

 

Acquisition of property, plant & equipment

 

 

(2,415)

 

 

(2,415)

Acquisition of joint ventures and businesses, net of cash acquired

 

 

(1,800)

 

 

(1,800)

Other investing activities, net

 

 

(637)

 

 

(114)

Net cash used by investing activities

 

 

(4,852)

 

 

(4,329)

Cash flows (used) provided by financing activities:

 

 

 

 

 

 

Net borrowings on revolving credit facility

 

 

(43)

 

 

(43)

Long–term borrowings - loan

 

 

20,000 

 

 

20,000 

Long–term borrowings - repayment

 

 

(24,500)

 

 

(24,500)

Dividends paid to stockholders

 

 

(10,520)

 

 

(10,520)

Other financing activities, net

 

 

(347)

 

 

(347)

Net cash used by financing activities

 

 

(15,410)

 

 

(15,410)

Effects of foreign currency translation

 

 

108 

 

 

109 

Net (decrease) increase in cash and cash equivalents

 

 

(193)

 

 

250 

Opening balance – cash and cash equivalents

 

 

11,184 

 

 

8,672 

Ending balance – cash and cash equivalents

 

 

10,991 

 

 

8,922 

 

(a)

As reported in the Company's 2014 third fiscal quarter Form 10-Q (filed on August 11, 2014), certain errors were identified in the Consolidated Statement of Cash Flows that impacted prior periods.  The errors related to the following:   treatment of accrued additions for property, plant and equipment, classification of debt financing fees and classification of unrealized gains or losses on investments in the Consolidated Statements of Cash Flows.   The prior period consolidated statements of cash flows were revised in the 2014 third fiscal quarter Form 10-Q to correct for these errors and the impacts of the corrections are reflected within the 'Previously Reported' columns above.

 

11

 


 

In connection with the preparation of the consolidated financial statements for the interim periods ended March 31, 2015, the Company identified errors in its previously issued financial statements for the interim periods ended March 31, 2014.  The Company did not properly report sales and purchases to related parties in its Related Party Transactions footnote.  As a result of these errors, the Company understated sales to Aquila by $284 and $2,360 for the three and six months ended March 31, 2014, respectively, and understated sales to Nagase by $31 and $99 for the three and six months ended March 31, 2014, respectively.  Further, the Company understated sales to Aquila by $2,360 for the nine months ended June 30, 2014, understated sales to Nagase by $80 and $179 for the three and nine months ended June 30, 2014, respectively, understated sales to Nagase by $616 for the three months ended December 31, 2014, understated sales to Aquila by $215 for the fiscal year ended September 30, 2014 and understated sales to Nagase by $271 for the fiscal year ended September 30, 2014.  In accordance with accounting guidance presented in SAB 99, management assessed the materiality of these errors and concluded that they were not material to the Company’s financial statements for the three and six months ended March 31, 2014.  The Company is revising its financial statements for the three and six month periods ended March 31, 2014 to correct for these errors. 

 

(2)Recent Accounting Pronouncements

 

In July 2013, the Financial Accounting Standards Board (“FASB”) issued new guidance to reduce the diversity in presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss or a tax credit carryforward exists. This requires an unrecognized tax benefit to be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, with certain exceptions listed in the guidance.  This guidance was  adopted by the Company in the first quarter of fiscal 2015.  The adoption did not have a material impact on the Company’s consolidated financial statements.

 

In May 2014, the FASB issued new guidance for recognizing revenue from contracts with customers, which provides a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and will supersede most current revenue recognition guidance.  This guidance is effective for the Company in the first quarter of fiscal 2018.  In April 2015, the FASB proposed a one year deferral of the effective date of the new revenue standard for the new revenue standard.  Early adoption is not permitted.  The Company is currently evaluating the impact that adoption of this guidance will have on its consolidated financial statements.

 

In June 2014, the FASB issued new guidance on accounting for share-based payments requiring a specific performance target to be achieved in order for employees to become eligible to vest in the awards when that performance target may be achieved after the requisite service period for the award.  This update further clarifies that compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the period for which the requisite service has already been rendered.  This guidance is effective for the Company in the first quarter of fiscal 2017.  Early adoption is permitted.  The Company is currently evaluating the impact that adoption of this guidance will have on its consolidated financial statements.

 

In August 2014, the FASB issued new guidance on determining when and how to disclose going-concern uncertainties in the financial statements. The new standard requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of doubt about the entity’s ability to continue as a going concern.  An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity’s ability to continue as a going concern.  This guidance is effective for the Company in the first quarter of fiscal 2017, with early adoption permitted.  The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial statements.

 

In November 2014, the FASB issued new guidance on accounting for pushdown accounting in the event of a business combination.  This update provides an acquired entity with an option to apply

12

 


 

pushdown accounting in its separate financial statements upon occurrence of an event in which an acquirer obtains control of the acquired entity.  This guidance was adopted by the Company in the first quarter of fiscal 2015.  The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.

 

In January 2015, the FASB issued new guidance on accounting for unusual and infrequently occurring items, which eliminates the concept of extraordinary items.  An unusual and infrequently occurring item will no longer be classified as an extraordinary item and segregated from ordinary operations in the income statement, but will be shown as a component of income from continuing operations or separately disclosed in notes to the financial statements.  This guidance is effective for the Company in the first quarter of fiscal 2017, with early adoption permitted.  The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial statements.

 

In February 2015, the FASB issued amended guidance on the model used to evaluate whether certain legal entities should be consolidated.  This guidance is effective for the Company in the first quarter of fiscal 2017.  Early adoption is permitted.  The Company is currently evaluating the impact that adoption of this guidance will have on its consolidated financial statements.

 

 

(3)Fair Value Measurements

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date in a principal or most advantageous market.  Fair value is a market-based measurement that is determined based on inputs, which refer broadly to assumptions that market participants use in pricing assets or liabilities.  A fair value hierarchy with three tiers has been established to prioritize the inputs to valuation techniques used to measure fair value.  The hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs.  Level 1 inputs include quoted prices in active markets for identical assets and liabilities.  Level 2 inputs consist of observable inputs other than quoted prices in active markets or indirectly observable through corroboration with observable market data.  Level 3 inputs are not observable in the market and include management’s own judgments about the assumptions market participants would use in pricing the asset or liability based on the best information available in the circumstances.

 

Financial assets measured at fair value on a recurring basis are summarized below:

 

 

13

 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair Value Measurements at March 31, 2015 Using

(Dollars in Thousands)

Quoted Prices in Active Markets for Identical Assets
(Level 1)

 

Significant Other Observable Inputs (Level 2)

 

Significant Unobservable Inputs
(Level 3)

Asset Category

 

 

 

 

 

 

 

 

Cash equivalents

$

115 

 

$

 -

 

$

 -

Mutual funds

 

3,616 

 

 

 -

 

 

 -

Available-for-sale securities

 

 -

 

 

1,524 

 

 

 -

Total financial assets at fair value

$

3,731 

 

$

1,524 

 

$

 -

 

 

 

 

 

 

 

 

 

 

Fair Value Measurements at September 30, 2014 Using

(Dollars in Thousands)

Quoted Prices in Active Markets for Identical Assets
(Level 1)

 

Significant Other Observable Inputs (Level 2)

 

Significant Unobservable Inputs
(Level 3)

Asset Category

 

 

 

 

 

 

 

 

Cash equivalents

$

105 

 

$

 -

 

$

 -

Mutual funds

 

3,629 

 

 

 -

 

 

 -

Available-for-sale securities

 

 -

 

 

2,382 

 

 

 -

Total financial assets at fair value

$

3,734 

 

$

2,382 

 

$

 -

 

Following is a description of each category in the fair value hierarchy and the financial assets and liabilities of the Company that were included in each category at March 31, 2015 and September 30, 2014, measured on a recurring basis.

 

The Level 1 financial assets were comprised of investments in trading securities, which are reported in other long-term assets.  The investments are held in a Rabbi trust for benefits under the Company’s deferred compensation plan.  Under the plan, participants designate investment options to serve as the basis for measurement of the notional value of their accounts.  The investments include a money market fund and mutual funds that are publicly traded.  The fair values of the shares or underlying securities of these funds are based on quoted market prices.

 

The Level 2 financial assets are long-term investments consisting primarily of fixed income mutual funds, classified as available-for-sale securities.  These are reported in other long-term assets.  The investments in fixed income mutual funds are valued based on the net asset value of the underlying securities as provided by the investment account manager.  The investments are not restricted or subject to a lockup and may be redeemed on demand.  Notice within a certain period of time prior to redemption is not required.

 

The Company’s long term debt is classified as Level 2.  The carrying amount of the Company’s long-term debt approximated fair value as the stated interest rates were variable in relation to prevailing market rates.

 

The Company recorded a liability for contingent consideration during the second quarter of fiscal 2014 related to the acquisition of ilumark GmbH and the launch of its new medical products.  The liability was recorded at fair value, which was determined using a discounted cash flow model based on assumptions and projections relevant to revenues.  A discount rate of 11% was used and payments are projected to occur in fiscal 2016 and 2017.  The fair value of the contingent consideration was $774 as of March 31, 2015 and is reported in other accrued expenses and other non-current liabilities at $131 and $643, respectively.  The contingent consideration liability is classified as Level 3.

 

There were no transfers between fair value hierarchy levels during the period.

 

 

14

 


 

(4)Income per Common Share

 

Basic net income per share was computed by dividing net income available to common stockholders for the period by the weighted average number of shares of common stock outstanding during the period.  Diluted net income per share was computed by dividing net income available to common stockholders for the period by the weighted average number of shares of common stock that would have been outstanding assuming dilution from stock-based compensation awards during the period.    

 

The following table sets forth the computation of net income per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended
March 31,

 

Six Months Ended
March 31,

(Dollars in Thousands, Except per Share)

2015

 

2014
(As Restated)

 

2015

 

2014
(As Restated)

Basic Net Income per Share:

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributed to Landauer, Inc.

 

$

3,547 

 

$

4,514 

 

$

7,924 

 

$

8,335 

Less:  Income allocated to unvested restricted stock

 

 

18 

 

 

46 

 

 

47 

 

 

91 

Net income available to common stockholders

 

$

3,529 

 

$

4,468 

 

$

7,877 

 

$

8,244 

Basic weighted average shares outstanding

 

 

9,493 

 

 

9,460 

 

 

9,464 

 

 

9,441 

Net income per share - Basic

 

$

0.37 

 

$

0.47 

 

$

0.83 

 

$

0.87 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted Net Income per Share:

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributed to Landauer, Inc.

 

$

3,547 

 

$

4,514 

 

$

7,924 

 

$

8,335 

Less:   Income allocated to unvested restricted stock

 

 

18 

 

 

46 

 

 

47 

 

 

91 

Net income available to common stockholders

 

$

3,529 

 

$

4,468 

 

$

7,877 

 

$

8,244 

Basic weighted average shares outstanding

 

 

9,493 

 

 

9,460 

 

 

9,464 

 

 

9,441 

Effect of dilutive securities